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Background: Considerable controversy exists regarding the association between dietary calcium intake and risk of
mortality from cardiovascular disease and all causes. Therefore, we performed a meta-analysis of prospective cohort
studies to examine the controversy.
Methods: We identified relevant studies by searching MEDLINE, Embase, and the Cochrane Library databases
between 1 September 2013 and 30 December 2013. Reference lists of relevant articles were also reviewed.
Observational prospective studies that reported relative risks and 95% confidence intervals for the association of
calcium intake with cardiovascular and all-cause mortality were eligible. Study-specific relative risks were pooled
using a random-effects model.
Results: In this meta-analysis, 11 prospective studies with 12 independent cohorts, involving 757,304 participants,
were eligible. There was evidence of a non-linear association between dietary calcium intake and risk of mortality
from cardiovascular disease (P for non-linearity <0.01) and all causes (P for non-linearity <0.01). A dose-response
analysis showed a U-shaped relationship between dietary calcium intake and cardiovascular mortality. Intakes that
were lower and higher than around 800 mg/day were gradually associated with a higher risk of cardiovascular
mortality. For all-cause mortality, we also observed a threshold effect at intakes around 900 mg/day. The risk of
all-cause mortality did not decrease further at intakes above 900 mg/day.
Conclusions: This meta-analysis of prospective cohort studies suggests that dietary calcium intake is associated
with cardiovascular mortality in a U-shaped manner and that high dietary calcium intake (>900 mg/day) is not
associated with a decreased risk of all-cause mortality.
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Calcium is one of the most common and abundant min-
erals in the body and has many critical biologic functions.
The body tightly controls circulating levels of calcium, usu-
ally maintaining a constant range of 1.0 to 1.2 mmol/L [1].
Increasing calcium intake has been recommended by many
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unless otherwise stated.bone health. Consequently, more than 50% of older men
and almost 70% of older women in the US are regular users
of calcium supplements [2,3].
The health effects of calcium intake on non-skeletal
outcomes, including cardiovascular and all-cause mortal-
ity, have received growing attention. Some prospective
studies found an inverse association between dietary cal-
cium intake and mortality from ischemic heart disease
or cardiovascular disease (CVD) [4,5]. By contrast, sev-
eral recent re-analyses of randomized trials showed that
calcium supplements are associated with a higher risk of
both ischemic heart disease and stroke, which are two
major causes of cardiovascular mortality [6-8]. Thus, the
current evidence for an association between calcium intaketd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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insufficient and controversial. Differences in calcium
intake doses, which were higher in the trials, may have
led to the differences between the observational studies
and randomized trials.
Therefore, to evaluate whether the association between
calcium intake and risk of mortality from CVD and all
causes varies by levels of calcium intake, we conducted a
dose-response meta-analysis of prospective cohort studies.
Methods
Search strategy
We followed the Meta-analysis of Observational Studies
in Epidemiology [9] for conducting and reporting the
present study (Additional file 1). We carried out a meta-
analysis of prospective cohort studies that evaluated the
association between dietary calcium intake and risk of
mortality from CVD and all causes.
We systematically searched databases, including
MEDLINE (from 1950), Embase (from 1980), and the
Cochrane Library (from 1960), between 1 September
2013 and 30 December 2013 (last date searched). The
computer-based searches included the key words ‘calcium
intake’, ‘calcium supplements’, ‘calcium supplementation’,
‘cardiovascular mortality’, ‘all-cause mortality’, ‘cause of
death’, ‘cardiovascular diseases’, ‘coronary heart disease’,
‘ischemic heart disease’, ‘coronary artery disease’, ‘myocardial
infarction’, ‘stroke’, ‘prospective studies’, and ‘follow-up
studies’. No language restrictions were imposed on pub-
lications. Furthermore, we identified additional articles
by manually searching the reference lists of pertinent ar-
ticles and recent reviews.
Study selection
To be included, studies had to be prospective cohort
studies that reported relative risks (RRs) with 95% confi-
dence intervals (CIs) for the association between dietary
calcium intake and mortality from CVD and all causes.
We excluded studies with ecological, case-control, or
cross-sectional designs; studies with no adjustment for
potential confounders; and studies that did not report
RRs or hazard ratios and corresponding 95% CIs.
Data extraction and quality assessment
Data extraction was conducted using a standardized data
collection form. The primary exposure variable was dietary
calcium intake, which was estimated from foods only, but
we also examined supplemental calcium. Outcomes of
interest in this study were mortality from CVD and mortal-
ity from all causes. All outcomes were classified based on
the World Health Organization’s International Classification
of Disease criteria. Two authors (JL and YO) independently
selected studies and performed the data extraction. We
recorded the following characteristics for each identifiedpaper: first author, publication year, cohort name, geo-
graphical location, sample size of the cohort and number
of outcomes, follow-up (years), age at entry, sex, assessment
method of dietary calcium intake, ascertainment of out-
comes, variables that entered into the multivariable model
as potential confounders, and RRs and the associated meas-
ure of variance for all categories of dietary calcium intake.
Study quality was evaluated by using the Newcastle-Ottawa
quality assessment scale [10]. The system allowed a total
score of 0 to 9 points (9 represented the highest quality).
To perform a dose-response meta-analysis, we assigned
the median level of calcium intake in each category to
the corresponding RR of that category for each study.
If medians were not reported, we used the mean level of
calcium intake in each category. If the highest category of
the studies was open-ended, the difference from the low-
est range to the median was considered equivalent to the
same difference in the closest adjacent category.
Data synthesis and analysis
We used the results of the original studies from multi-
variable models with the most complete adjustment for
potential confounders. We utilized a random-effects
model to account for inter-study variation and to pro-
vide a more conservative effect than a fixed-effects
model. Between-study heterogeneity was assessed using
the Cochran’s Q test (significance level at P <0.10) [11].
I2 was also evaluated to quantify the proportion of in-
consistency across studies [12].
We tested for potential non-linearity in the association
between calcium intake and mortality from CVD and all
causes using a random-effects dose-response meta-analysis
[13]. A potential curvilinear relationship was assessed using
restricted cubic splines with three knots at fixed percentiles
(10%, 50%, and 90%) of the distribution [14]. We first esti-
mated a restricted cubic spline model with a generalized
least-squares regression taking into account the correlation
within each set of published RRs [13-15]. We then pooled
the study-specific estimates using the restricted maximum
likelihood method [16]. A P-value for a non-linear relation-
ship was calculated by testing the null hypothesis that the
coefficient of the second spline was equal to zero [17].
We used STATA version 12.0 (StataCorp LP, College
Station, TX, USA) to analyze the data. Except where other-
wise specified, P <0.05 was considered statistically significant.
Results
Literature search
Overall, the search initially identified 1,894 reports
(Figure 1). After excluding duplicates and papers that
did not meet the inclusion criteria, we obtained 13 full
articles of potentially relevant studies. After full-text
reviews, 2 out of the 13 articles were excluded because they
reported risk of coronary heart disease or stroke rather than
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12 independent cohorts fulfilled our inclusion criteria.
Dai et al.’s report [21] included data from two inde-
pendent cohorts.
Study characteristics
Table 1 illustrates the characteristics of the 11 included
studies, all of which had prospective cohort design. Of
these, nine prospective studies [5,18,20-26] reported data
on the relation of dietary calcium intake and total CVD
mortality, and six studies [5,20-22,26,28] on all-cause
mortality. Six prospective studies [20,22-25,27] examined
the relationship between supplemental calcium intake and
cardiovascular mortality. One study consisted entirely of
men, two of women only, and eight of both men and
women. Study length ranged from 5.5 years to 28 years.
Three studies were conducted in the US, one in Canada,
three in China, and four in Europe.
One study used one week food frequency recall to meas-
ure dietary calcium intake, and all other studies used food
frequency questionnaires. All studies provided the estimates
adjusted for age. Most of the studies also controlled for en-
ergy intake and smoking (n = 10), alcohol consumption and
body mass index (n = 9), physical activity (n = 8), and other
dietary variables or nutrients (n = 7). No study scored the
highest level of quality (maximum 9), with five of the nine
studies scoring 8, five scoring 7, and one scoring 6.1894 Studies identified through literature search 
1822 Studies excluded on the basis of titles and abstracts  
215 Redundant articles 
1607 Irrelevant publications 
72 Potentially relevant studies for evaluation 
59 Studies excluded 
16 Reviews, editorials, or case-control studies 
9 Animals studies or assessing serum calcium 
11 Levels of calcium intake not reported 
23 Relevant outcomes not reported 
13 full-text studies reviewed  
2 Papers excluded from remaining studies 
1 risk of coronary heart disease or stroke reported 
1 reporting myocardial infarction risk 
11 Prospective studies included in meta-analysis  
Figure 1 Flow chart of study selection. Shows literature search for
prospective cohort studies of calcium intake in relation to
cardiovascular and all-cause mortality.Dietary calcium intake and cardiovascular mortality
Cardiovascular mortality was evaluated in nine prospective
cohort studies [5,18,20-26] comprising 709,499 subjects
and at least 21,457 deaths from CVD. The exact number of
deaths is unknown because one study [26] did not report
the number of deaths.
The pooled RR of cardiovascular mortality comparing
the highest and lowest level of dietary calcium intake was
0.97 (95% CI: 0.89 to 1.07; P = 0.60), with no heterogeneity
among the studies (I2 = 18.8%; P = 0.28) (Figure 2). The
Begg rank correlation test and Egger linear regression test
indicated no significant publication bias (Begg, P = 0.75;
Egger, P = 0.11).
The dose-response analysis revealeda non-linear associ-
ation (P <0.01). The tendency of a U-shaped association be-
tween dietary calcium intake and deaths from CVD was
visualized by the pattern of the spline curves in Figure 3.
At intakes below 800 mg/day, there was a higher risk
of cardiovascular mortality with lower intake of dietary
calcium. Intakes around 800 mg/day conferred the
lowest risk of cardiovascular mortality. By contrast, at
intakes above 800 mg/day, a higher intake was progres-
sively associated with a higher risk of cardiovascular
mortality. Compared to individuals with 800 mg/day of
dietary calcium intake, the predicted RRs for cardio-
vascular mortality were 1.08 (95% CI: 0.98 to 1.20) for
individuals with 500 mg/day of calcium intake, 1.01
(95% CI: 0.98 to 1.04) for 1,000 mg/day, 1.05 (95% CI:
1.01 to 1.09) for 1,200 mg/day, and 1.10 (95% CI: 1.02
to 1.18) for 1,400 mg/day.
Dietary calcium intake and all-cause mortality
All-cause mortality was investigated in six studies
[5,20-22,26,28] involving a total of 225,189 subjects
and at least 21,055 deaths from all causes. One study
[28] was not included in our analysis because it re-
ported only one intake level of calcium. The summary
relative risks of all-cause mortality comparing the
highest and lowest level of dietary calcium intake was
0.83 (95% CI: 0.70 to 1.00; P = 0.05), with significant
heterogeneity among the studies (I2 = 74.9%; P = 0.003;
Additional file 2: Figure S1). No significant publication bias
was observed (Begg test, P = 0.46; Egger test, P = 0.34).
We found evidence of a non-linear association (P <0.01;
Additional file 2: Figure S2). We found a threshold effect
at intakes of about 900 mg/day. Compared to intakes of
900 mg/day, a lower intake was gradually associated with
a higher risk of all-cause mortality. At intakes above
900 mg/day, risk of all-cause mortality did not reduced
with the increase of dietary calcium intake.
Supplemental calcium intake and cardiovascular mortality
Six studies [20,22-25,27] reported the relationship between
supplemental calcium intake and cardiovascular mortality
Table 1 Summary of prospective studies that examined the association between calcium intake and risk of mortality








Calcium intake (mg/day) Covariates in fully adjusted model Quality
score










Dietary calcium: M: <458, 458
to 584, 584 to 762, >762; W:
<417, 417 to 529, 529 to 688,
>688; Calcium supplement
users versus nonusers
Age, smoking, sex, BMI, PASE, alcohol,
education, history of diabetes and
hypertension, energy intake, percentage
of energy from total fat, percentage of
energy from saturated fat, and calcium
supplemental use
7





Dietary calcium: <408, 408
to 600, ≥600
Age, smoking, sex, BMI, physical activity,
alcohol, education, marriage status, tea
drinking, use of ginseng, use of calcium
supplement, use of multivitamin, intakes
of total energy, SFA, phosphorus, fiber,
retinol, vitamin E, folic acid, sodium,
potassium and zinc
7





Dietary calcium: <408, 408
to 600, ≥600
Same as above 7








Dietary calcium: per 500 Age, study center, education, BMI, health
status, smoking, alcohol, physical activity,
sun exposure, self-reported comorbidity
(in men and women: hypertension, heart
disease, stroke, type 2 diabetes, COPD,
and kidney stones; in women only:
osteoporosis, thyroid disease, IBD, breast
cancer, and uterine cancer; in men only:
prostate cancer), and medication (aspirin
use or other NSAIDs)
7
Michaëlsson et al. 2013,
Swedish mammography
cohort [22]





Dietary calcium: <600, 600 to
999, 1,000 to 1,399, ≥1,400;
any calcium users versus
nonusers
Age, smoking, BMI, physical activity, total
energy and vitamin D intake, a healthy
dietary pattern, height, living alone,












Dietary calcium: M: 478, 616,
739, 898, 1,247 (medians); W:
408, 532, 648, 798, 1,101
(medians); Calcium
supplement: 0, <400, 400
to 1,000, ≥1,000
Age, BMI, smoking, race, physical activity,
alcohol, education, marital status, health
status, supplemental calcium intake, fruit
and vegetable intake, red meat intake,
whole grain intake, total fat intake, and
total caloric intake, and use of menopausal
hormone therapy (for women)
8








Dietary calcium: <500, 500 to
1,000, 1,000 to 1,300, >1,300
Age, smoking, BMI, sex, race/ethnicity,
physical activity, alcohol, poverty to income
ratio, comorbidity index, serum vitamin D,
vigorous and total energy intake
7




35 to 64 CVD mortality (267) 11 years; 263,780
person years*
Dietary calcium: 513, 675,
820, 1,130 (medians); Calcium
Age, sex, smoking, BMI, physical activity,
alcohol, education, history of diabetes,




















Table 1 Summary of prospective studies that examined the association between calcium intake and risk of mortality (Continued)
only users versus nonusers of
supplements
of total energy, vitamin D, SFAs and
total protein






Age, education, place of residence,
diabetes mellitus, high blood pressure,
BMI, waist to hip ratio, hormone
replacement therapy, physical activity,
smoking, and intake of energy, alcohol,
saturated fatty acids, whole grain
products, and fruits, and vegetables
7





Dietary calcium: <1230, 1230
to 1598, ≥1599
Age, smoking, physical activity, alcohol,
marital status, education, health status,
waist-to-hip ratio, energy-adjusted
dietary fiber, SFA, vitamin D, and
phosphorus intake
7





4 to 79 CVD mortality (800) 9.6 years; 515,029
person years
Dietary calcium: M: 250, 363,
449, 536, 665 (medians); W:
266, 379, 462, 545, 667
(medians)
Age, smoking, BMI, alcohol, hypertension,
diabetes, and intakes of total energy
6










Dietary calcium: M: ≤585,
585 to 1245, >1245; W: ≤445,
445 to 850, >850
Age, energy intake, systolic blood
pressure
5
aPerson time estimated by multiplying number of participants by average follow-up time. BMI, body mass index; CaMos, Canadian Multicentre Osteoporosis Study; COPD, chronic obstructive pulmonary disease; COSM,
Cohort of Swedish Men; CVD, cardiovascular disease; IBD, inflammatory bowel disease; IWHS, Iowa Women’s Health Study; JACC, Japan Collaborative Cohort study; M, men; NA, not available; NHANES III, Third National
Health and Nutrition Examination Survey; NIH-AARP, National Institutes of Health - AARP Diet and Health Study; NSAIDs, aspirin use or other non-steroidal anti-inflammatory drugs; PASE, Physical Activity Scale for the



















Figure 2 Dietary calcium intake and risk of cardiovascular mortality. Forest plot presents association between dietary calcium intake and risk
of cardiovascular mortality when comparing the highest to the lowest level of dietary calcium intake. CI, confidence interval; RR, relative risk.
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nificant association. Use of calcium supplements was
not significantly associated with cardiovascular mor-
tality in comparison with non-use of any supplements
(RR = 0.96; 95% CI: 0.82 to 1.13; P = 0.66; Additional file 2:
Figure S3).
Subgroup and sensitivity analyses
To test the robustness of the results and investigate the
sources of between-study heterogeneity, we conducted
subgroup analyses. Table 2 presents the different subgroup
analyses of studies on cardiovascular and all-cause mortal-
ity. The associations between dietary calcium intake andFigure 3 Dose-response analyses relating dietary calcium
intake to cardiovascular mortality. Relative risks of cardiovascular
mortality associated with total dietary calcium intake. Calcium intake
was modeled with restricted cubic splines by a random-effects
dose-response model. A calcium intake of 800 mg/d was used as
the reference to estimate all relative risks.risk of cardiovascular and all-cause mortality did not differ
substantially by study location, sex, or whether vitamin D
status was controlled for in models.
For all-cause mortality, subgroup analyses showed that
dietary calcium intakes were not significantly associated
with an increased mortality risk in studies with more
than 10 years of follow-up, but not in studies with less
than 10 years.
We also performed a sensitivity analysis. Exclusion
of one study [20] that enrolled people aged over
65 years yielded similar results for cardiovascular mortality
(RR = 1.00; 95% CI: 0.94 to 1.07; P = 0.90) or all-cause
mortality (RR = 0.89; 95% CI: 0.76 to 1.05; P = 0.18).
Discussion
This meta-analysis of prospective studies indicates a
U-shaped relationship between dietary calcium intake
and cardiovascular mortality. Compared with intakes
of 800 mg/day, both lower and higher intakes were
gradually associated with a higher risk of cardiovascu-
lar mortality. For all-cause mortality, we also observed
a threshold effect at intakes about 900 mg/day. Intakes
above 900 mg/day were not associated with a decrease
in risk of all-cause mortality.
Vitamin D, directly or indirectly, enhances renal con-
servation of the absorbed calcium and intestinal absorp-
tion of calcium [29]. Some studies have noted that
serum 25-hydroxyvitamin D levels, the major circulating
metabolite of vitamin D, are inversely correlated with
CVD incidence rates [30,31]. The co-administration of
calcium with vitamin D may reduce the adverse effect of
dietary calcium. Therefore, to explore a potential source of
heterogeneity in our results, we also considered vitamin D
status associated with dietary calcium intake. However,
Table 2 Stratified analysis on the associations of dietary calcium intake and mortality from cardiovascular disease and
all causes
Cardiovascular mortality All-cause mortality
Number RR (95% CI) Pa I2(%) Number RR (95% CI) Pa I2(%)
Location:
United States 2 1.04 (0.98 to 1.10) 0.50 0.0 - - - -
Europe 4 0.90 (0.73 to 1.12) 0.20 36.1 3 0.85 (0.68 to 1.06) 0.08 61.1
Asia 3 0.95 (0.81 to 1.12) 0.56 0.0 2 0.80 (0.52 to 1.23) 0.002 89.9
Sex:
Male and female 3 0.99 (0.70 to 1.39) 0.22 33.3 2 0.66 (0.53 to 0.82) 0.45 0.0
Male 5 0.88 (0.74 to 1.06) 0.06 55.2 2 0.91 (0.74 to 1.11) 0.14 54.7
Female 5 1.04 (0.95 to 1.13) 0.90 0.0 2 0.90 (0.63 to 1.29) 0.001 90.6
Follow-up time:
>10 years 6 1.03 (0.97 to 1.08) 0.46 0.0 3 0.98 (0.89 to 1.07) 0.56 0.0
≤10 years 3 0.87 (0.70 to 1.08) 0.28 21.5 2 0.71 (0.60 to 0.83) 0.26 22.0
Controlling for vitamin D status in models:
Yes 4 0.92 (0.74 to 1.15) 0.22 32.7 2 0.87 (0.65 to 1.16) 0.03 80.0
No 5 1.02 (0.97 to 1.08) 0.44 0.0 3 0.79 (0.57 to 1.10) 0.006 80.7
aP for heterogeneity. CI, confidence interval; RR, relative risk.
Wang et al. BMC Medicine 2014, 12:158 Page 7 of 10
http://www.biomedcentral.com/1741-7015/12/158subgroup analyses showed that dietary calcium intakes
were not significantly associated with all-cause mortality
in studies that adjusted for vitamin D status.
Heterogeneity could also be caused by differences in
dietary magnesium intake. None of the included studies
adjusted for dietary magnesium intake. However, some
studies showed that dietary magnesium intake is asso-
ciated with reduced mortality from CVD [32,33]. It is
possible that magnesium counters the effects of cal-
cium on risk of CVD. Furthermore, some studies also
suggest that balance between calcium and magnesium
may help prevent CVD [21,34].
Another possible explanation for the differences between
the studies might be the effects of sex and age on the risks
of CVD and mortality rates with respect to dietary calcium
or supplemental calcium intake. Supplemental calcium in-
take is associated with an elevated CVD mortality in men
but not in women [23]. A recent study by Paik et al. [35]
found that supplement calcium intake did not increase
CVD risk in women. Dietary supplement use is more com-
mon in women than in men [36]. Additionally, male users
of calcium supplements may start taking calcium supple-
ments at an older age [23]. However, in the present study,
sensitivity analyses by excluding one study in older people
showed similar results.
Women with a calcium intake below 600 mg/day had
a higher risk of stroke in the Nurses’ Health Study [37].
There was higher mortality from ischemic heart disease
with a total calcium intake below 700 mg/day in the Iowa
Women’s Health Study cohort [4]. An intake below about
500 mg/day was also associated with higher rate of strokein Japanese people with habitual low calcium intake [18].
In our study, at intakes below 800 mg/day, there was a
higher risk of cardiovascular mortality with lower intake
of calcium. Our results also indicated that intakes of about
800 mg/day, which corresponds to the recommended
daily intake for Swedish women aged more than 50 years
[38], conferred the lowest risk of cardiovascular mortality.
Moreover, a recent meta-analysis by Larsson et al. [39]
showed that high dietary calcium intake is related to a
lower risk of stroke in populations with low to moderate
calcium intakes. Therefore, increased dietary calcium intake
may be associated with reduced cardiovascular mortality
risk at low to moderate calcium intakes.
In addition, our study showed that, in comparison with
intakes of 800 mg/day, a higher intake was associated with
increased risk of cardiovascular mortality. In a re-analysis
of randomized trials, a higher rate of myocardial infarction
was observed for calcium supplementation [40]. The re-
sults from a meta-analysis of randomized trials of calcium
supplements also indicated a higher risk of cardiovascular
events in women with intake levels of dietary calcium above
800 mg/day, but not in women with lower intake levels [6].
Thus, it is likely that increasing dietary calcium intake may
increase risk of cardiovascular mortality in individuals who
already consume adequate amounts of calcium.
Our results are concordant with findings from a recent
review [41] in which calcium intake was not associated
with risk of CVD when comparing the highest and lowest
intake levels. However, this study [41] did not evaluate the
dose-response relationship of dietary calcium intake and
CVD. In the current study, dose-response analysis showed
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cardiovascular mortality was U-shaped. The null findings
to date for comparing the highest and lowest calcium in-
take categories likely related to the non-linear association.
Moreover, a recent meta-analysis [42] showed that higher
calcium intake may be associated with a reduction in risk
of colorectal cancer beyond 1,000 mg/day. There could
therefore be beneficial effects of calcium intake on risk of
some cancers, such as colorectal. However, a meta-analysis
of randomized controlled trials suggested no effect of cal-
cium on the risk of total cancer [43]. In the present study, a
high calcium intake (>900 mg/day) was not associated with
a decreased rate of all-cause mortality. We found that, for
all-cause mortality, dietary calcium intakes were not signifi-
cantly associated with an increased mortality risk in studies
with more than 10 years of follow-up, but not in studies
with less than 10 years. It is possible that the follow-up pe-
riods in these studies were too short to identify the true as-
sociations with mortality. In fact, longer induction periods
were observed for cancers than for CVD.
For calcium supplement use, a previous review [44]
suggested that the evidence regarding the relationship
between calcium supplement use and increased CVD
risk is insufficient. A study by Radford et al. [45] showed
that the effects of calcium supplements on cardiovascular
risk did not differ across varying patient subpopulations,
such as younger people and those with low dietary calcium
intake. The present study also found no evidence that
calcium supplements increased the risk of cardiovascular
mortality. Thus, more longitudinal studies are needed to
confirm or refute the results of our study.
Calcium is a vital electrolyte and part of the etiological
pathway of CVD. Nevertheless, calcium has mainly been
explored in relation to bone health. As a concern in
osteoporosis management, it is only recently that the
cardiovascular safety of calcium supplementation has
been queried [46]. Calcium blood concentrations are
under tight homeostatic control by the calciotropic
hormones [47]. Alterations in calcium homeostasis caused
by diets that are low or very high in calcium can alter blood
levels of calcium and calciotropic hormones [48]. Calcium
intakes that are too low may cause mortality or CVD risk
through pathways that affect blood pressure [49,50], insulin
secretion and sensitivity [51-53], and blood cholesterol
concentrations [53]. Likewise, excessive amounts of calcium
may also exert a harmful effect on cardiovascular health
by inducing a hypercoagulable state [54,55]. Many studies
show that high levels of circulating fibroblast growth
factor-23 are associated with higher risk of cardiovascular
events and all-cause mortality [56-58], whereas calcium-
enriched meals can raise serum levels of fibroblast growth
factor-23 [59]. High calcium intake may also increase risk
of mortality associated with vascular and soft tissue calcifi-
cation [60,61] and effects on arterial stiffness [62,63].We used estimates from the fully adjusted models from
all included studies in our analyses to reduce the potential
for confounding. We conducted the dose-response meta-
analysis to evaluate non-linear relationships, which helped
to test the shape of these possible associations. Some
limitations of this meta-analysis should be addressed.
All included studies were observational in nature. The
results may be subject to residual confounding or un-
measured factors. Moreover, dietary calcium intake was
measured at baseline in the included studies. During the
long follow-up, participants may have changed their diets,
including changing their dietary calcium intakes. Therefore,
we were not able to evaluate change in dietary calcium
intake during follow-up. Besides, calcium intake levels
were assessed by food frequency questionnaires in most
studies. Measurement errors of calcium intake were pos-
sible. However, the prospective nature of the included
studies could have led to an underestimation of the real
association and could not explain the positive associations
we observed in this study.
Our results, together with previous studies, suggest
that increasing dietary calcium intake is associated with de-
creased mortality risk at low to moderate calcium intakes,
whereas it is not associated with a decreased risk of mortal-
ity at high calcium intakes. Thus, intake recommendations
for calcium should consider individual characteristics and
should focus on people with low intake levels of calcium,
rather than increasing the intake of those with adequate
amounts of calcium.Conclusions
This meta-analysis suggests a U-shaped relationship be-
tween dietary calcium intake and risk of cardiovascular
mortality. A high calcium intake (>900 mg/day) was not
associated with a reduced risk of all-cause mortality.Additional files
Additional file 1: Meta-analysis of Observational Studies in
Epidemiology Checklist.
Additional file 2: Figure S1. Association between dietary calcium
intake and risk of all-cause mortality when comparing the highest to
lowest level of dietary calcium intake. Figure S2. Dose-response analyses
relating dietary calcium intake to all-cause mortality. RRs of all-cause mortality
associated with dietary calcium intake. Calcium intake was modeled
with restricted cubic splines by a random-effects dose-response model.
A calcium intake of 500 mg/d was used as the reference to estimate all
RRs. Figure S3. Association between calcium supplement use and risk
of cardiovascular mortality when comparing users of calcium supplements
with non-users.
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